Form 4 for BCAX Bicara Therapeutics Inc.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0000950170-24-107661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-09-18 | 2024-09-16 | BCAX | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | +1.01M | 54.1K | New | — |
| DMI | 2024-09-18 | 2024-09-16 | BCAX | FIL Ltd | See Remark 1 | C - Cnv Deriv | — | -1.01M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-16 | C | A | 352,876 | — | 1,013,853 | I Eight Roads Ventures India Healthcare IV, L.P. | — | — | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |
| 2 | Common | Common Stock | 2024-09-16 | C | A | 606,885 | — | 660,977 | I Eight Roads Ventures India Healthcare IV, L.P. | — | — | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |
| 3 | Common | Common Stock | 2024-09-16 | C | A | 54,092 | — | 54,092 | I Eight Roads Ventures India Healthcare IV, L.P. | — | — | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |
| 4 | Derivative | Series B Preferred Stock | 2024-09-16 | C | D | 606,885 | — | 0 | I Eight Roads Ventures India Healthcare IV, L.P. | — · — to — | 606,885 Common Stock | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |
| 5 | Derivative | Series Seed Preferred Stock | 2024-09-16 | C | D | 54,092 | — | 0 | I Eight Roads Ventures India Healthcare IV, L.P. | — · — to — | 54,092 Common Stock | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |
| 6 | Derivative | Series C Preferred Stock | 2024-09-16 | C | D | 352,876 | — | 0 | I Eight Roads Ventures India Healthcare IV, L.P. | — · — to — | 352,876 Common Stock | (F1) On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock. |